Fe-protoporphyrin IX (FPIX)

Fe-protoporphyrin IX is the iron-bound form of protoporphyrin IX, central to the heme biosynthesis pathway in *Plasmodium falciparum* as well as a key product of host hemoglobin digestion during malaria infection[1][3]. In the parasite’s digestive vacuole, hemoglobin is degraded, releasing toxic Fe-protoporphyrin IX (heme), which must be detoxified by crystallization to inert hemozoin to ensure parasite survival[1][3][5]. Antimalarial drugs such as artemisinins are activated by the iron within this molecule, forming drug-heme adducts and reactive radicals that kill the parasite[3][5]. Disruption of heme biosynthesis, inhibition of hemozoin formation, or alkylation of Fe-protoporphyrin IX are recognized modes of action for several widely used antimalarials[3][5]. Resistance in *P. falciparum* frequently arises by mutations affecting hemoglobin digestion, drug transport, or heme detoxification[2][3]. Fe-protoporphyrin IX is not a receptor, enzyme, or transporter, but a prosthetic group and metabolic intermediate whose chemical properties are exploited for therapeutic intervention against malaria.

Other names

hemeferriprotoporphyrin IXFe(II)-protoporphyrin IXFe(III)-protoporphyrin IXferrihemehematin

Artemisinins: activated by Fe(II)-protoporphyrin IX, leading to drug radical formation, alkylation of macromolecules, and inhibition of hemozoin crystallization Chloroquine: binds to FPIX, inhibiting its detoxification, leading to accumulation of toxic heme Griseofulvin: induces N-methyl protoporphyrin IX, a potent ferrochelatase inhibitor, halting the synthesis of heme and inhibiting parasite growth